These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 352038)

  • 21. Types of erythrogenic toxins (ET) in patients with scarlet fever.
    Begovac J
    Zentralbl Bakteriol; 1992 Oct; 277(3):271-2. PubMed ID: 1486226
    [No Abstract]   [Full Text] [Related]  

  • 22. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.
    Kamezawa Y; Nakahara T; Nakano S; Abe Y; Nozaki-Renard J; Isono T
    Infect Immun; 1997 Sep; 65(9):3828-33. PubMed ID: 9284159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathophysiological effects of the erythrogenic toxins (author's transl)].
    Hríbalová V
    Cesk Epidemiol Mikrobiol Imunol; 1980 Jul; 29(4):201-7. PubMed ID: 6448100
    [No Abstract]   [Full Text] [Related]  

  • 24. Scarlet fever and types of erythrogenic toxins produced by the infecting streptococcal strains.
    Knöll H; Srámek J; Vrbová K; Gerlach D; Reichardt W; Köhler W
    Zentralbl Bakteriol; 1991 Dec; 276(1):94-106. PubMed ID: 1789905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Streptococcus pyogenes: preparation of type-specific antigen and titration of type-specific antibodies (author's transl)].
    Havlícek J
    Cesk Epidemiol Mikrobiol Imunol; 1975 Mar; 24(2):108-14. PubMed ID: 124221
    [No Abstract]   [Full Text] [Related]  

  • 26. [The passive hemagglutination test for detection of antibodies to scarlet fever toxin].
    Silich VA; Fiks LI; Cherkasskaia RS
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Aug; 49(8):57-62. PubMed ID: 4673601
    [No Abstract]   [Full Text] [Related]  

  • 27. Purification and characterization of erythrogenic toxins. II. Communication: in vivo biological activities of erythrogenic toxin produced by streptococcus pyogenes strain ny-5.
    Hríbalová V; Knöll H; Gerlach D; Köhler W
    Zentralbl Bakteriol A; 1980; 248(3):314-22. PubMed ID: 7013358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of a mitogen characteristic of group A streptococci (Streptococcus pyogenes).
    Gerlach D; Günther E; Köhler W; Vettermann S; Fleischer B; Schmidt KH
    Zentralbl Bakteriol; 1995 Jan; 282(1):67-82. PubMed ID: 7734831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue cages for study of experimental streptococcal infection in rabbits. II. Humoral and cell-mediated immune response to erythrogenic toxins.
    Knöll H; Holm SE; Gerlach D; Kühnemund O; Köhler W
    Immunobiology; 1985 Mar; 169(2):116-27. PubMed ID: 3997195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptococcal superantigens and the return of scarlet fever.
    Hurst JR; Brouwer S; Walker MJ; McCormick JK
    PLoS Pathog; 2021 Dec; 17(12):e1010097. PubMed ID: 34969060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of the immunological and epidemiological activity of purified sorbed scarlet fever toxin].
    MITEL'MAN SL
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():70-5. PubMed ID: 13771373
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relationship between anti-streptokinase levels and hemolytic streptococcal types in scarlet fever].
    Shimizu H; Iimura T; Yagishita N; Nagase K
    Kansenshogaku Zasshi; 1973 Dec; 47(12):522-3. PubMed ID: 4208601
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serological study on scarlet fever].
    Nakamizo Y; Tsuji S; Shimizu H
    Kansenshogaku Zasshi; 1973 Dec; 47(12):519-21. PubMed ID: 4208600
    [No Abstract]   [Full Text] [Related]  

  • 34. THE ROLE OF TEMPERATE BACTERIOPHAGE IN THE PRODUCTION OF ERYTHROGENIC TOXIN BY GROUP A STREPTOCOCCI.
    ZABRISKIE JB
    J Exp Med; 1964 May; 119(5):761-80. PubMed ID: 14157029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship of type specific M antigen content, streptolysin O titer, serological M type and proteinase production of group A streptococci isolated from the patients of scarlet fever (author's transl)].
    Kobayashi S; Hamada A
    Kansenshogaku Zasshi; 1982 Jan; 56(1):20-5. PubMed ID: 6177808
    [No Abstract]   [Full Text] [Related]  

  • 36. Lymphocyte-stimulating activity of scarlet fever toxin.
    Hríbalová V; Pospísil M
    Experientia; 1973 Jun; 29(6):704-5. PubMed ID: 4578079
    [No Abstract]   [Full Text] [Related]  

  • 37. [Streptococcal erythrogenic toxin as a nonspecific sensitizer of the animal organism].
    Anatoliĭ SA; Iunusova MI; Shapiro NI; Vasil'eva TG
    Tr Inst Im Pastera; 1982; 57():65-7. PubMed ID: 7170738
    [No Abstract]   [Full Text] [Related]  

  • 38. [Induction of immune interferon by erythrogenic toxins A and B from Streptococcus pyogenes].
    Tonew E; Gerlach D; Tonew M; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):463-71. PubMed ID: 6817542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Virulent and toxigenic properties of beta-hemolytic streptococci in relation to the scarlatina epidemic process].
    Gladkova KK; Dodonov VN; Bliumental' KV; Cherkasskaia RS; Severov AM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):24-7. PubMed ID: 4272990
    [No Abstract]   [Full Text] [Related]  

  • 40. Mitogenic activity of extracellular cationic products produced by group A streptococci; analysis of the lymphocyte response.
    Suzuki M; Vogt A
    Clin Exp Immunol; 1986 Oct; 66(1):132-8. PubMed ID: 3542316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.